Ssa1 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of Ssa1, a member of the Hsp70 (Heat Shock Protein 70) family of molecular chaperones. Ssa1 plays a critical role in protein homeostasis within the cell, ensuring the proper folding of nascent polypeptides, preventing the aggregation of misfolded proteins, and aiding in the refolding or degradation of damaged proteins. Like other Hsp70 family members, Ssa1 is involved in a wide range of cellular processes, including protein transport across membranes, the assembly and disassembly of protein complexes, and the regulation of protein quality control systems. By acting as a molecular chaperone, Ssa1 helps maintain the functional integrity of the proteome, particularly under conditions of cellular stress, such as heat shock, oxidative stress, or exposure to toxins. Inhibitors of Ssa1 disrupt these processes by interfering with its chaperone activity, which can lead to the accumulation of misfolded or damaged proteins.
The mechanism of action for Ssa1 inhibitors typically involves binding to the ATPase domain of the protein, preventing the ATP-driven conformational changes that are necessary for its chaperone function. Some inhibitors may also interfere with Ssa1's ability to bind client proteins or co-chaperones, thereby disrupting its role in protein folding and stabilization. By inhibiting Ssa1, these compounds can affect the overall protein quality control system, potentially leading to imbalances in cellular proteostasis. This can disrupt essential processes such as protein synthesis, degradation, and cellular responses to stress. Research into Ssa1 inhibitors provides valuable insights into the role of molecular chaperones in maintaining protein homeostasis and the broader regulatory networks that ensure proper protein function. Understanding how Ssa1 contributes to these critical cellular mechanisms helps illuminate the complex interplay between protein folding, stress responses, and cellular health.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
VER 155008 | 1134156-31-2 | sc-358808 sc-358808A | 10 mg 50 mg | $203.00 $842.00 | 9 | |
An adenosine-derived inhibitor that binds to the ATPase domain of Hsp70 proteins, likely impacting Ssa1 by inhibiting its ATP-dependent chaperone activity, essential for its function in protein folding and stability. | ||||||
Apoptosis Activator VII, Apoptozole | 1054543-47-3 | sc-221257 | 10 mg | $243.00 | 1 | |
Inhibitor that targets the ATPase activity of Hsp70, potentially reducing Ssa1 activity in stress response and protein repair by interfering with its ability to hydrolyze ATP, a crucial step in the chaperone cycle. | ||||||
Malformin C | 59926-78-2 | sc-280953 sc-280953A | 250 µg 1 mg | $119.00 $349.00 | ||
A cyclic peptide that has shown inhibitory effects on Hsp70s, suggesting it could impair Ssa1 function in yeast by interfering with its substrate binding or ATPase activity, crucial for its role in protein homeostasis. | ||||||
MKT-077 | 147366-41-4 | sc-507514 | 5 mg | $175.00 | ||
A rhodacyanine dye derivative that selectively accumulates in mitochondria and inhibits mitochondrial Hsp70; its effect on Ssa1 could be through disruption of mitochondrial protein handling where Ssa1 is involved. | ||||||
Pifithrin-μ | 64984-31-2 | sc-203195 sc-203195A | 10 mg 50 mg | $130.00 $379.00 | 4 | |
This compound binds directly to Hsp70 and inhibits its chaperone activity, potentially impacting Ssa1 by preventing it from properly assisting in the folding and assembly of other proteins. | ||||||
Heat Shock Protein Inhibitor I | 218924-25-5 | sc-221709 | 5 mg | $97.00 | 5 | |
A benzylidene lactam compound known to inhibit heat shock protein synthesis, potentially reducing Ssa1 levels and activity indirectly by limiting its availability in cells under stress. | ||||||